The (confusing!) language of AMR: ChatGPT tries to help!
Dear All (Wonkish alert! Not technical but lengthy … so settle in and enjoy the ride!): Regular readers will know of my fascination with language:
13 June 2024
No Comments
Something Different
EPA (part 5): Interagency Framework on AMR Risks of Antibacterial and Antifungal Pesticides
This is the fifth of a 5-part newsletter series. There is an initial 27 Sep 2023 newsletter introducing the EPA concept note, a second (28 Sep 2023) newsletter that expands on
11 October 2024
No Comments
Which came first: The drug or resistance to the drug?
Dear All, Although it seems entirely reasonable that the “Which came first?” chicken vs. egg riddle can be resolved in favor of the egg, a pair
4 February 2024
No Comments
NIAID BAA – Biodefense focus / Fireside Chat on diagnostics and more
Dear All, We are swimming in Broad Agency Announcements aka BAAs! As a refresher, I recently shared a BAA from the CDC and one from
29 January 2023
No Comments
Fireside Chat with AMR Action Fund CIO Martin Heidecker
Dear All, Ahead of World Antimicrobial Awareness Week, I sat down with AMR Action Fund Chief Investment Officer Martin Heidecker for a Fireside Chat. It was
17 November 2022
No Comments
WHO 2020 clinical/preclinical pipeline review; Chat with WHO’s Peter Beyer
Dear All, WHO have today updated their 2019 clinical/preclinical pipeline review by releasing their 2020 analyses of both the clinical and pre-clinical antibacterial product pipelines
14 April 2021
No Comments
Where’s the innovation? / Indian Priority Pathogen List / DTR video explainer
Dear All, Three things briefly this evening: First, the observation about the limited degree of innovation across products in Phases 1-3 in the recent newsletter
17 March 2021
No Comments
Starting 18 May: #SquashSuperbugs, Salt in My Soul (movie), and more!
Dear All, Building on last year’s call from PFID to declare 18 May the annual “Squash Superbugs Day of Action,” we have a flurry of activity
17 May 2022
No Comments
RFP: Gender inequality in AMR (with a focus on sub-Saharan Africa)
Dear All, Continuing with the theme of socio-economic inequality and AMR that we discussed in prior newsletters (31 Jan 2022, “RFP: Support For Creating Antimicrobial
13 February 2022
No Comments
RFP: Climate-Sensitive Infectious Disease Modelling
Dear All, And now for something really different! With the recent GRAM report (20 Jan 2022 newsletter) showing that AMR is linked to more deaths that
2 February 2022
No Comments